2-chloro-[1,1'-biphenyl]-4-carbonitrile | 5728-37-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-chloro-[1,1'-biphenyl]-4-carbonitrile
• 英文别名: 3-Chloro-4-phenylbenzonitrile；3-chloro-4-phenylbenzonitrile
• CAS: 5728-37-0
• 化学式: C₁₃H₈ClN
• 分子量: 213.666
• InChiKey: MMAJWRTUDVOXOD-UHFFFAOYSA-N

物化性质

• 沸点：
  328.0±30.0 °C(Predicted)
• 密度：
  1.33 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-chloro-[1,1'-biphenyl]-4-carbonitrile 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 生成 2-Chlor-biphenyl-4-carbonsaeure
  参考文献：
  名称：

  一些取代的联苯-4-羧酸，4-联苯基乙酸和4-氨基联苯的合成

  摘要：

  描述了一系列取代的联苯-4-羧酸和4-氨基联苯的合成。包括母体联苯-4-羧酸，4-联苯基乙酸和三种取代的4-联苯基乙酸的制剂。

  DOI：

  10.1039/j39660000840
• 作为产物：
  描述：

  2-氯-4-硝基联苯 在 盐酸 、 铁粉 作用下， 以 乙醇 为溶剂， 生成 2-chloro-[1,1'-biphenyl]-4-carbonitrile
  参考文献：
  名称：

  一些取代的联苯-4-羧酸，4-联苯基乙酸和4-氨基联苯的合成

  摘要：

  描述了一系列取代的联苯-4-羧酸和4-氨基联苯的合成。包括母体联苯-4-羧酸，4-联苯基乙酸和三种取代的4-联苯基乙酸的制剂。

  DOI：

  10.1039/j39660000840

文献信息

• Silver-Catalyzed Arylation of (Hetero)arenes by Oxidative Decarboxylation of Aromatic Carboxylic Acids
  作者：Jian Kan、Shijun Huang、Jin Lin、Min Zhang、Weiping Su

  DOI：10.1002/anie.201408630

  日期：2015.2.9

  arylation of heteroarenes by oxidative decarboxylation of aromatic carboxylic acids. To address this challenge, the silver‐catalyzed intermolecular Minisci reaction of aromatic carboxylic acids was developed. With an inexpensive silver salt as a catalyst, this new reaction enables a variety of aromatic carboxylic acids to undergo decarboxylative coupling with electron‐deficient arenes or heteroarenes regardless

  Minisci反应的长期挑战是通过芳族羧酸的氧化脱羧实现杂芳基的芳基化。为了应对这一挑战，开发了银催化的芳香族羧酸分子间Minisci反应。用廉价的银盐作为催化剂，这种新的反应可以实现各种芳族羧酸的经历脱羧耦合用缺电子的芳烃或杂芳烃不管取代基上的芳族羧酸的位置，因此消除了对需要邻-取代的芳族羧酸，这是以前报道的方法的局限性。
• Novel non-ATP competitive small molecules targeting the CK2 α/β interface
  作者：Paul Brear、Andrew North、Jessica Iegre、Kathy Hadje Georgiou、Alexandra Lubin、Laura Carro、William Green、Hannah F. Sore、Marko Hyvönen、David R. Spring

  DOI：10.1016/j.bmc.2018.05.011

  日期：2018.7

  Increased CK2 levels are prevalent in many cancers. Combined with the critical role CK2 plays in many cell-signaling pathways, this makes it a prime target for down regulation to fight tumour growth. Herein, we report a fragment-based approach to inhibiting the interaction between CK2 alpha and CK2 beta at the alpha-beta interface of the holoenzyme. A fragment, CAM187, with an IC50 of 44 mu M and a molecular weight of only 257 gmol(-1) has been identified as the most promising compound. Importantly, the lead fragment only bound at the interface and was not observed in the ATP binding site of the protein when co-crystallised with CK2 alpha. The fragment-like molecules discovered in this study represent unique scaffolds to CK2 inhibition and leave room for further optimisation.
• A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066
  作者：Claudia De Fusco、Paul Brear、Jessica Iegre、Kathy Hadje Georgiou、Hannah F. Sore、Marko Hyvönen、David R. Spring

  DOI：10.1016/j.bmc.2017.04.037

  日期：2017.7

  Recently we reported the discovery of a potent and selective CK2 alpha inhibitor CAM4066. This compound inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (alpha D pocket). Here we describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy. Specifically, we aimed to develop inhibitors by linking a high-affinity fragment anchored in the alD site to a weakly binding warhead fragment occupying the ATP site. Moreover, we describe the remarkable impact that molecular modelling had on the development of this novel chemical tool. The work described herein shows potential for the development of a novel class of CK2 inhibitors. (C) 2017 Published by Elsevier Ltd.